Aquarius Surgical Technologies (ASTI) AI Stock Analysis

Aquarius Surgical Technologies

(CNQX:ASTI)

Select Model

Rating:44Neutral

Price Target:CAD 0.02▲(0.00% Upside)

Action:upgraded

Date:10/21/26

Low score driven primarily by extremely weak financials including negative equity and cash burn. Technical momentum offers minor offset while valuation metrics remain poor.

Positive Factors

Revenue ReboundThe 20.3% TTM revenue rebound provides evidence of renewed demand for the company’s surgical technologies and related solutions. If maintained, improving sales can broaden operating scale, support customer adoption, and create a stronger base for eventual cost absorption.

Negative Factors

Persistent UnprofitabilityThe extremely negative TTM net margin, together with ongoing EBIT and EBITDA losses, shows that revenue and gross profit are not covering the company’s operating and non-operating cost base. Persistent losses weaken internal funding capacity and make a durable earnings recovery uncertain.

Aquarius Surgical Technologies (ASTI) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 115.92K
Dividend Yield: ―
Average Volume (3M): 37.59K
Price to Earnings (P/E): -0.3
Beta (1Y): -0.31
Revenue Growth: 8.66%
EPS Growth: -545.88%
Country: Canada
Employees: 3
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Aquarius Surgical Technologies Business Overview & Revenue Model

Company Description

Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings through...

Aquarius Surgical Technologies Financial Statement Overview

Summary

Severe distress from negative equity over $6.5M, high debt near $7M, large operating losses, and deeply negative cash flows despite modest revenue growth.

Income Statement

25Negative

Balance Sheet

10Very Negative

Cash Flow

18Very Negative

Financial statement breakdown
Breakdown	TTM	Jun 2026	Jun 2025	Jun 2023	Mar 2022	Jun 2020
Income Statement
Total Revenue	91.44K	91.44K	91.20K	205.25K	327.66K	958.74K
Gross Profit	40.16K	33.48K	47.31K	132.85K	130.30K	378.25K
EBITDA	655.51K	-241.88K	-832.81K	-456.62K	-611.35K	-1.18M
Net Income	-651.71K	-651.71K	-1.17M	-757.66K	-859.20K	-1.61M
Balance Sheet
Total Assets	1.91M	1.91M	1.95M	574.44K	894.98K	1.66M
Cash, Cash Equivalents and Short-Term Investments	44.51K	44.51K	7,559	107.38K	158.19K	105.19K
Total Debt	6.94M	6.94M	6.47M	4.04M	3.24M	2.02M
Total Liabilities	8.34M	8.34M	7.72M	5.18M	4.11M	2.35M
Stockholders Equity	-6.42M	-6.42M	-5.77M	-4.61M	-3.21M	-689.15K
Cash Flow
Free Cash Flow	-116.36K	-116.36K	-383.29K	-256.92K	-117.38K	-1.07M
Operating Cash Flow	-116.36K	-116.36K	-383.29K	-252.56K	-112.16K	-951.17K
Investing Cash Flow	0	0	-1.80M	-4,358	-5,221	-86.99K
Financing Cash Flow	153.31K	153.31K	2.08M	242.29K	129.59K	1.02M

Aquarius Surgical Technologies Technical Analysis

Technical Analysis SentimentPositive

Last Price0.01

Price Trends

50DMA0.01Positive

100DMA0.01Positive

200DMA0.01Positive

Market Momentum

MACD0.00Negative

RSI81.36Negative

STOCH33.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Positive. The current price of 0.01 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.01, and above the 200-day MA of 0.01, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 81.36 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:ASTI.

Aquarius Surgical Technologies Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:ASTI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:PRN	50Neutral	CAD 335.37M	-6.79	-62.45%	―	59.60%	32.53%
TSE:ASG	47Neutral	CAD 8.98M	-5.36	-34.32%	―	-5.42%	-5.37%
TSE:VPT	46Neutral	CAD 15.43M	-6.13	56.40%	―	89.06%	37.62%
TSE:ASTI	44Neutral	CAD 413.99K	-0.27	23.95%	―	8.66%	-545.88%
TSE:PINK	38Underperform	CAD 27.62M	-1.41	-303.05%	―	35.27%	58.34%

* Healthcare Sector Average

Performance Comparison

TSE:ASTI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:ASTI	Aquarius Surgical Technologies	0.01	0.00	0.00%
TSE:ASG	Aurora Spine	0.12	-0.18	-61.67%
TSE:PINK	Perimeter Medical Imaging Ai Inc	0.18	-0.07	-26.53%
TSE:PRN	Profound Medical	9.18	0.83	9.94%
TSE:VPT	VentriPoint Diagnostics	0.08	-0.02	-20.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 21, 2026

Aquarius Surgical Technologies AI Stock Analysis